Stocky turns companies like DIAMOND BIOFUND INC into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Hold. 6901.TW scores as a Value Compounder (61/100) with reasonable operational fundamentals, but Leadership Alignment is middling (51/100) and Vulnerability is acute—the company relies solely on financial reserves as a buffer against sector or operational stress, with no structural moat or competitive advantage to cushion downturns. Investors should monitor cash burn and management capital allocation before adding exposure.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for DIAMOND BIOFUND INC:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 61/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates DIAMOND BIOFUND INC (6901.TW) at 61/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. 6901.TW scores as a Value Compounder (61/100) with reasonable operational fundamentals, but Leadership Alignment is middling (51/100) and Vulnerability is acute—the company relies solely on financial reserves as a buffer against secto
6901.TW's current Stocky Verdict is 61/100, placing it in the "Hold" band. This composite combines a 61/100 Compounder score, 51/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for DIAMOND BIOFUND INC yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
DIAMOND BIOFUND INC scores 51/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
DIAMOND BIOFUND INC's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to DIAMOND BIOFUND INC.
Sign up free and unlock the full analysis on 6901.TW — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 6901.TW in the app.
